NYC hospitals terminate Palantir contracts amid privacy concerns even as the AI firm accelerates its expansion into British healthcare systems.

New York City hospitals have discontinued their relationships with Palantir, citing concerns over the controversial data analytics company's practices

Palantir is simultaneously expanding its presence in the UK, suggesting growing international adoption despite privacy and ethical criticisms

The move reflects ongoing tension between healthcare institutions and AI vendors regarding data security, patient privacy, and algorithmic transparency

The contrasting outcomes in US versus UK markets highlight divergent regulatory approaches and institutional comfort levels with AI firm partnerships